AAGL Advisory Statement: Essure Hysteroscopic Sterilization.

1553-4650/$ see http://dx.doi.org/1 The American Association of Gynecologic Laparoscopists (AAGL) publishes advisory statements on the state of minimally invasive gynecology to improve the overall quality of women’s gynecologic care. The AAGL follows a process to ensure that any conflicts of interest are disclosed and appropriately addressed and that relationships with manufacturers and other third parties do not influence the development process. The Board of Directors of the AAGL formed a task force of leaders in the field of minimally invasive gynecology to provide the members of the society a document outlining the current status of hysteroscopic sterilization with the Essure device (Bayer, Whippany, NJ). The advisory statement has been developed by a group of individuals with experience and interest in the assessment of minimally invasive gynecologic surgery. The goal of this document is to present an unbiased view, informed by the available literature, of the critical aspects of the use of hysteroscopic sterilization.